Syngenta Launches New Seed Treatment

BASEL, Switzerland, May 18, 2011 /PRNewswire/ -- Syngenta announced today the launch of VIBRANCE™, a proprietary seed treatment fungicide based on the new active ingredient sedaxane. VIBRANCE, which has been tailored specifically for the seed treatment market, protects major crops against a wide range of diseases carried in soil and air as well as against seed infection. Its properties also result in outstanding protection of the entire plant root system.

John Atkin, Syngenta COO, said: "Research is increasingly focusing on the ability of roots to efficiently use water and nutrients as a key to further improvements in crop productivity. VIBRANCE is a major step towards integrated root health solutions and will play an important role in enforcing Syngenta's global leadership position in seed treatment."

Recent results in the field demonstrate that VIBRANCE delivers enhanced root health leading to improved crop performance under a wide range of conditions. VIBRANCE is now available in Argentina for the coming growing season. It will be combined with other Syngenta Seed Care compounds as a complete solution for cereals. Further registrations across all major crops worldwide are expected over the next two years.

Syngenta is one of the world's leading companies with more than 26,000 employees in over 90 countries dedicated to our purpose: Bringing plant potential to life. Through world-class science, global reach and commitment to our customers we help to increase crop productivity, protect the environment and improve health and quality of life. For more information about us please go to www.syngenta.com.

Cautionary Statement Regarding Forward-Looking Statements

This document contains forward-looking statements, which can be identified by terminology such as 'expect', 'would', 'will', 'potential', 'plans', 'prospects', 'estimated', 'aiming', 'on track' and similar expressions. Such statements may be subject to risks and uncertainties that could cause the actual results to differ materially from these statements. We refer you to Syngenta's publicly available filings with the U.S. Securities and Exchange Commission for information about these and other risks and uncertainties. Syngenta assumes no obligation to update forward-looking statements to reflect actual results, changed assumptions or other factors. This document does not constitute, or form part of, any offer or invitation to sell or issue, or any solicitation of any offer, to purchase or subscribe for any ordinary shares in Syngenta AG, or Syngenta ADSs, nor shall it form the basis of, or be relied on in connection with, any contract therefor.

SOURCE Syngenta